🚀 VC round data is live in beta, check it out!
Steris Valuation Multiples
Discover revenue and EBITDA valuation multiples for Steris and similar public comparables like Mettler Toledo, Halma, Illumina, Sartorius and more.
Steris Overview
About Steris
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
Founded
2014
HQ
Employees
17.8K
Website
Financials (LTM)
EV
$26B
Steris Financials
Steris reported last 12-month revenue of $6B and EBITDA of $2B.
In the same LTM period, Steris generated $3B in gross profit, $2B in EBITDA, and $1B in net income.
Revenue (LTM)
Steris P&L
In the most recent fiscal year, Steris reported revenue of $5B and EBITDA of $2B.
Steris expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $6B | XXX | $5B | XXX | XXX | XXX |
| Gross Profit | $3B | XXX | $2B | XXX | XXX | XXX |
| Gross Margin | 44% | XXX | 44% | XXX | XXX | XXX |
| EBITDA | $2B | XXX | $2B | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 29% | XXX | XXX | XXX |
| EBIT Margin | 23% | XXX | 23% | XXX | XXX | XXX |
| Net Profit | $1B | XXX | $924M | XXX | XXX | XXX |
| Net Margin | 17% | XXX | 17% | XXX | XXX | XXX |
| Net Debt | — | — | $2B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Steris Stock Performance
Steris has current market cap of $24B, and enterprise value of $26B.
Market Cap Evolution
Steris' stock price is $247.77.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $26B | $24B | 0.0% | XXX | XXX | XXX | $9.42 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSteris Valuation Multiples
Steris trades at 4.4x EV/Revenue multiple, and 15.2x EV/EBITDA.
EV / Revenue (LTM)
Steris Financial Valuation Multiples
As of March 11, 2026, Steris has market cap of $24B and EV of $26B.
Equity research analysts estimate Steris' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Steris has a P/E ratio of 24.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $24B | XXX | $24B | XXX | XXX | XXX |
| EV (current) | $26B | XXX | $26B | XXX | XXX | XXX |
| EV/Revenue | 4.4x | XXX | 4.7x | XXX | XXX | XXX |
| EV/EBITDA | 15.2x | XXX | 16.3x | XXX | XXX | XXX |
| EV/EBIT | 18.8x | XXX | 20.5x | XXX | XXX | XXX |
| EV/Gross Profit | 9.9x | XXX | 10.8x | XXX | XXX | XXX |
| P/E | 24.2x | XXX | 26.3x | XXX | XXX | XXX |
| EV/FCF | 30.2x | XXX | 32.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Steris Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Steris Margins & Growth Rates
Steris' revenue in the last 12 month grew by 6%.
Steris' revenue per employee in the last FY averaged $0.3M.
Steris' rule of 40 is 35% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Steris' rule of X is 45% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Steris Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 29% | XXX | XXX | XXX |
| EBITDA Growth | 3% | XXX | 8% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 35% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 45% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 2% | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 26% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Steris Public Comps
See public comps and valuation multiples for other Medical Devices and Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Mettler Toledo | XXX | XXX | XXX | XXX | XXX | XXX |
| Halma | XXX | XXX | XXX | XXX | XXX | XXX |
| Illumina | XXX | XXX | XXX | XXX | XXX | XXX |
| Sartorius | XXX | XXX | XXX | XXX | XXX | XXX |
| DexCom | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Steris M&A Activity
Steris acquired XXX companies to date.
Last acquisition by Steris was on XXXXXXXX, XXXXX. Steris acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Steris
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSteris Investment Activity
Steris invested in XXX companies to date.
Steris made its latest investment on XXXXXXXX, XXXXX. Steris invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Steris
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Steris
| When was Steris founded? | Steris was founded in 2014. |
| Where is Steris headquartered? | Steris is headquartered in United States. |
| How many employees does Steris have? | As of today, Steris has over 17K employees. |
| Who is the CEO of Steris? | Steris' CEO is Daniel A. Carestio. |
| Is Steris publicly listed? | Yes, Steris is a public company listed on NYSE. |
| What is the stock symbol of Steris? | Steris trades under STE ticker. |
| When did Steris go public? | Steris went public in 1992. |
| Who are competitors of Steris? | Steris main competitors are Mettler Toledo, Halma, Illumina, Sartorius. |
| What is the current market cap of Steris? | Steris' current market cap is $24B. |
| What is the current revenue of Steris? | Steris' last 12 months revenue is $6B. |
| What is the current revenue growth of Steris? | Steris revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Steris? | Current revenue multiple of Steris is 4.4x. |
| Is Steris profitable? | Yes, Steris is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Steris? | Steris' last 12 months EBITDA is $2B. |
| What is Steris' EBITDA margin? | Steris' last 12 months EBITDA margin is 29%. |
| What is the current EV/EBITDA multiple of Steris? | Current EBITDA multiple of Steris is 15.2x. |
| What is the current FCF of Steris? | Steris' last 12 months FCF is $858M. |
| What is Steris' FCF margin? | Steris' last 12 months FCF margin is 15%. |
| What is the current EV/FCF multiple of Steris? | Current FCF multiple of Steris is 30.2x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.